1IA
VANI icon

1620 Investment Advisors’s Vivani Medical VANI Stock Holding History

1620 Investment Advisors’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9
Closed -$9 – 716
2025
Q1 		$9 Buy
+9
New +$10 ﹤0.01% 683

Other funds holding VANI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TWM
Tanager Wealth Management Goring On Thames, United Kingdom $1.03B AUM 16.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1620 Investment Advisors's VANI Position: Q2 2025 in Review

1620 Investment Advisors sold out of Vivani Medical (VANI) in Q2 2025, closing a stake of 9 shares — an estimated $9 sold.

1620 Investment Advisors first reported a position in VANI in Q1 2025 and held it in 1 quarter. The position peaked at $9 in Q1 2025. 32 funds tracked by Wall St. Rank hold VANI as of Q2 2025.

  • 1620 Investment Advisors reported no remaining Vivani Medical position as of Q2 2025 after selling out during the quarter.
  • 1620 Investment Advisors sold 9 Vivani Medical shares in Q2 2025, an estimated $9.
  • 1620 Investment Advisors first reported a position in Vivani Medical in Q1 2025 and held it in 1 quarter.
  • 1620 Investment Advisors's Vivani Medical position peaked at $9 in Q1 2025.
  • 32 funds tracked by Wall St. Rank held Vivani Medical as of Q2 2025.

Based on 1620 Investment Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.